Zealand Pharma A/S (ZELA)

196.70
-1.90(-0.96%)
  • Volume:
    129,791
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    196.70 - 201.00

ZELA Overview

Prev. Close
198.6
Day's Range
196.7-201
Revenue
134.25M
Open
198.6
52 wk Range
69.55-211
EPS
-25.77
Volume
129,791
Market Cap
10.16B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
227,886
P/E Ratio
-7.02
Beta
1.06
1-Year Change
47.77%
Shares Outstanding
51,405,298
Next Earnings Date
09 Mar 2023
What is your sentiment on Zealand Pharma?
or
Market is currently closed. Voting is open during market hours.

Zealand Pharma A/S Company Profile

Zealand Pharma A/S Company Profile

Employees
237
Market
Denmark
  • Type:Equity
  • Market:Denmark
  • ISIN:DK0060257814
  • S/N:51513186

Zealand Pharma A/S, a biotechnology company, engages in the discovery, development, and commercialization of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin and Lyxumia; Dasiglucagon, a single use syringe or autoinjector for the treatment of severe hypoglycemia, congenital hyperinsulinism, and post bariatric surgery hypoglycemia; and Dasiglucagon dual-hormone artificial pancreas for automated diabetes management. The company’s pipeline includes Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion Pharmaceuticals, Inc.; and Beta Bionics, Inc. The company was incorporated in 1998 and is headquartered in Copenhagen, Denmark.

Read More

Analyst Price Target

Average235.60 (+19.78% Upside)
High284.4114
Low171
Price196.7
No. of Analysts9
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong SellStrong SellSellBuyStrong Buy
Technical IndicatorsStrong SellStrong SellStrong SellStrong BuyStrong Buy
SummaryStrong SellStrong SellStrong SellStrong BuyStrong Buy